Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04084171 · ClinicalTrials.gov registry record · NA
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04084171 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 12 participants.
The verdict
NCT04084171, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
A single-arm, multi-center, clinical study to assess the safety profile of the Tandem t:slim X2 with Control-IQ system in children with T1D aged 2-6 years old under free living condition
Interventions
- DEVICE Tandem t:slim X2 with Control-IQ Technology + Dexcom G6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2019-10-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04084171
The ClinicalTrials.gov registry entry for NCT04084171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 is the first listed.
NCT04084171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04084171 about?
NCT04084171 is a clinical study titled "Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6". A single-arm, multi-center, clinical study to assess the safety profile of the Tandem t:slim X2 with Control-IQ system in children with T1D aged 2-6 years old under free living condition
What is the current status of trial NCT04084171?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-09-26. Estimated completion is 2019-10-23.
What interventions are being tested in trial NCT04084171?
The interventions under investigation include: Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 (DEVICE).
Who is sponsoring clinical trial NCT04084171?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.